Natural Capsules Limited — Board Meeting, 04-08-2025: Outcome of Board Meeting

Natural Capsules Ltd's board has approved its Q1 FY26 consolidated financial results. The company reported revenue from operations of ₹45.20 Cr, an increase year-on-year. However, it posted a consolidated net loss of ₹5.58 Cr for the quarter ended June 30, 2025, a swing from profit in previous periods. This loss is primarily attributed to its new subsidiary, Natural Biogenex Private Limited, which began commercial operations on March 31, 2025. While all expenses are now charged to the P&L, its full revenue potential is still developing, impacting current quarter profitability.